Literature DB >> 24211266

An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.

Lucy C Young1, Nicole Hartig1, Marta Muñoz-Alegre1, Juan A Oses-Prieto2, Sevi Durdu3, Sabine Bender1, Vineetha Vijayakumar4, Matteo Vietri Rudan1, Christina Gewinner1, Stephen Henderson1, Amit P Jathoul1, Rupinder Ghatrora5, Mark F Lythgoe5, Alma L Burlingame2, Pablo Rodriguez-Viciana6.   

Abstract

SHOC2 is mutated in Noonan syndrome and plays a key role in the activation of the ERK-MAPK pathway, which is upregulated in the majority of human cancers. SHOC2 functions as a PP1-regulatory protein and as an effector of MRAS. Here we show that SHOC2 and MRAS form a complex with SCRIB, a polarity protein with tumor suppressor properties. SCRIB functions as a PP1-regulatory protein and antagonizes SHOC2-mediated RAF dephosphorylation through a mechanism involving competition for PP1 molecules within the same macromolecular complex. SHOC2 function is selectively required for the malignant properties of tumor cells with mutant RAS, and both MRAS and SHOC2 play a key role in polarized migration. We propose that MRAS, through its ability to recruit a complex with paradoxical components, coordinates ERK pathway spatiotemporal dynamics with polarity and that this complex plays a key role during tumorigenic growth.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24211266     DOI: 10.1016/j.molcel.2013.10.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  51 in total

1.  Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Authors:  Myoungkun Jeoung; Eun Ryoung Jang; Jinpeng Liu; Chi Wang; Eric C Rouchka; Xiaohong Li; Emilia Galperin
Journal:  Cell Signal       Date:  2016-02-11       Impact factor: 4.315

Review 2.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

Review 3.  RAS Proteins and Their Regulators in Human Disease.

Authors:  Dhirendra K Simanshu; Dwight V Nissley; Frank McCormick
Journal:  Cell       Date:  2017-06-29       Impact factor: 41.582

4.  APT2 Inhibition Restores Scribble Localization and S-Palmitoylation in Snail-Transformed Cells.

Authors:  Jeannie L Hernandez; Dahvid Davda; Melanie Cheung See Kit; Jaimeen D Majmudar; Sang Joon Won; Margery Gang; Sirisha C Pasupuleti; Alexandria I Choi; Callie M Bartkowiak; Brent R Martin
Journal:  Cell Chem Biol       Date:  2017-01-05       Impact factor: 8.116

5.  HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold.

Authors:  Eun Ryoung Jang; Ping Shi; Jamal Bryant; Jing Chen; Vikas Dukhande; Matthew S Gentry; HyeIn Jang; Myoungkun Jeoung; Emilia Galperin
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

6.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 7.  Signalling scaffolds and local organization of cellular behaviour.

Authors:  Lorene K Langeberg; John D Scott
Journal:  Nat Rev Mol Cell Biol       Date:  2015-03-18       Impact factor: 94.444

Review 8.  New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.

Authors:  Keesha E Erickson; Oleksii S Rukhlenko; Richard G Posner; William S Hlavacek; Boris N Kholodenko
Journal:  Semin Cancer Biol       Date:  2018-03-05       Impact factor: 15.707

9.  Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers.

Authors:  Rita Sulahian; Jason J Kwon; Katherine H Walsh; Emma Pailler; Timothy L Bosse; Maneesha Thaker; Diego Almanza; Joshua M Dempster; Joshua Pan; Federica Piccioni; Nancy Dumont; Alfredo Gonzalez; Jonathan Rennhack; Behnam Nabet; John A Bachman; Amy Goodale; Yenarae Lee; Mukta Bagul; Rosy Liao; Adrija Navarro; Tina L Yuan; Raymond W S Ng; Srivatsan Raghavan; Nathanael S Gray; Aviad Tsherniak; Francisca Vazquez; David E Root; Ari J Firestone; Jeff Settleman; William C Hahn; Andrew J Aguirre
Journal:  Cell Rep       Date:  2019-10-01       Impact factor: 9.423

10.  Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy.

Authors:  Erin M Higgins; J Martijn Bos; Heather Mason-Suares; David J Tester; Jaeger P Ackerman; Calum A MacRae; Katia Sol-Church; Karen W Gripp; Raul Urrutia; Michael J Ackerman
Journal:  JCI Insight       Date:  2017-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.